IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Predicting significance of EGFR mutation existing in tissues and plasma concuurrently or alone to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) for advanced non-small cell lung cancer.
Wang, Yuyan; Wang, Jie; Bai, Hua; Wang, Zhijie; Duan, Jianchun; An, Tongtong; Zhao, Jun; Zhuo, Minglei; Wu, Meina; Wang, Shuhang
刊名JOURNAL OF CLINICAL ONCOLOGY
2013-05-20
suppl.S期:15
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000335419604622
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62578
专题北京大学临床肿瘤学院
作者单位1.Beijing Canc Hosp, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China
2.Peking Univ, Sch Oncol, Beijing Canc Hosp, Canc Hosp, Beijing 100871, Peoples R China
3.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Wang, Yuyan,Wang, Jie,Bai, Hua,et al. Predicting significance of EGFR mutation existing in tissues and plasma concuurrently or alone to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) for advanced non-small cell lung cancer.[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,suppl.S(15).
APA Wang, Yuyan.,Wang, Jie.,Bai, Hua.,Wang, Zhijie.,Duan, Jianchun.,...&Wang, Shuhang.(2013).Predicting significance of EGFR mutation existing in tissues and plasma concuurrently or alone to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) for advanced non-small cell lung cancer..JOURNAL OF CLINICAL ONCOLOGY,suppl.S(15).
MLA Wang, Yuyan,et al."Predicting significance of EGFR mutation existing in tissues and plasma concuurrently or alone to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) for advanced non-small cell lung cancer.".JOURNAL OF CLINICAL ONCOLOGY suppl.S.15(2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Yuyan]的文章
[Wang, Jie]的文章
[Bai, Hua]的文章
百度学术
百度学术中相似的文章
[Wang, Yuyan]的文章
[Wang, Jie]的文章
[Bai, Hua]的文章
必应学术
必应学术中相似的文章
[Wang, Yuyan]的文章
[Wang, Jie]的文章
[Bai, Hua]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。